BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 22437836)

  • 1. Multimode, cooperative mechanism of action of allosteric HIV-1 integrase inhibitors.
    Kessl JJ; Jena N; Koh Y; Taskent-Sezgin H; Slaughter A; Feng L; de Silva S; Wu L; Le Grice SF; Engelman A; Fuchs JR; Kvaratskhelia M
    J Biol Chem; 2012 May; 287(20):16801-11. PubMed ID: 22437836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosteric integrase inhibitor potency is determined through the inhibition of HIV-1 particle maturation.
    Jurado KA; Wang H; Slaughter A; Feng L; Kessl JJ; Koh Y; Wang W; Ballandras-Colas A; Patel PA; Fuchs JR; Kvaratskhelia M; Engelman A
    Proc Natl Acad Sci U S A; 2013 May; 110(21):8690-5. PubMed ID: 23610442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New class of HIV-1 integrase (IN) inhibitors with a dual mode of action.
    Tsiang M; Jones GS; Niedziela-Majka A; Kan E; Lansdon EB; Huang W; Hung M; Samuel D; Novikov N; Xu Y; Mitchell M; Guo H; Babaoglu K; Liu X; Geleziunas R; Sakowicz R
    J Biol Chem; 2012 Jun; 287(25):21189-203. PubMed ID: 22535962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric inhibition of human immunodeficiency virus integrase: late block during viral replication and abnormal multimerization involving specific protein domains.
    Gupta K; Brady T; Dyer BM; Malani N; Hwang Y; Male F; Nolte RT; Wang L; Velthuisen E; Jeffrey J; Van Duyne GD; Bushman FD
    J Biol Chem; 2014 Jul; 289(30):20477-88. PubMed ID: 24904063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Competitive Interplay between Allosteric HIV-1 Integrase Inhibitor BI/D and LEDGF/p75 during the Early Stage of HIV-1 Replication Adversely Affects Inhibitor Potency.
    Feng L; Dharmarajan V; Serrao E; Hoyte A; Larue RC; Slaughter A; Sharma A; Plumb MR; Kessl JJ; Fuchs JR; Bushman FD; Engelman AN; Griffin PR; Kvaratskhelia M
    ACS Chem Biol; 2016 May; 11(5):1313-21. PubMed ID: 26910179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication.
    Christ F; Voet A; Marchand A; Nicolet S; Desimmie BA; Marchand D; Bardiot D; Van der Veken NJ; Van Remoortel B; Strelkov SV; De Maeyer M; Chaltin P; Debyser Z
    Nat Chem Biol; 2010 Jun; 6(6):442-8. PubMed ID: 20473303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The A128T resistance mutation reveals aberrant protein multimerization as the primary mechanism of action of allosteric HIV-1 integrase inhibitors.
    Feng L; Sharma A; Slaughter A; Jena N; Koh Y; Shkriabai N; Larue RC; Patel PA; Mitsuya H; Kessl JJ; Engelman A; Fuchs JR; Kvaratskhelia M
    J Biol Chem; 2013 May; 288(22):15813-20. PubMed ID: 23615903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based virtual screening toward the discovery of novel inhibitors for impeding the protein-protein interaction between HIV-1 integrase and human lens epithelium-derived growth factor (LEDGF/p75).
    Panwar U; Singh SK
    J Biomol Struct Dyn; 2018 Sep; 36(12):3199-3217. PubMed ID: 28948865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LEDGF/p75-independent HIV-1 replication demonstrates a role for HRP-2 and remains sensitive to inhibition by LEDGINs.
    Schrijvers R; De Rijck J; Demeulemeester J; Adachi N; Vets S; Ronen K; Christ F; Bushman FD; Debyser Z; Gijsbers R
    PLoS Pathog; 2012; 8(3):e1002558. PubMed ID: 22396646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-catalytic site HIV-1 integrase inhibitors disrupt core maturation and induce a reverse transcription block in target cells.
    Balakrishnan M; Yant SR; Tsai L; O'Sullivan C; Bam RA; Tsai A; Niedziela-Majka A; Stray KM; Sakowicz R; Cihlar T
    PLoS One; 2013; 8(9):e74163. PubMed ID: 24040198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual inhibition of HIV-1 replication by integrase-LEDGF allosteric inhibitors is predominant at the post-integration stage.
    Le Rouzic E; Bonnard D; Chasset S; Bruneau JM; Chevreuil F; Le Strat F; Nguyen J; Beauvoir R; Amadori C; Brias J; Vomscheid S; Eiler S; Lévy N; Delelis O; Deprez E; Saïb A; Zamborlini A; Emiliani S; Ruff M; Ledoussal B; Moreau F; Benarous R
    Retrovirology; 2013 Nov; 10():144. PubMed ID: 24261564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Conformational Escape Reaction of HIV-1 against an Allosteric Integrase Inhibitor.
    Nakamura T; Nakamura T; Amano M; Miyakawa T; Yamagata Y; Matsuoka M; Nakata H
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32611758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small-molecule inhibitors of the LEDGF/p75 binding site of integrase block HIV replication and modulate integrase multimerization.
    Christ F; Shaw S; Demeulemeester J; Desimmie BA; Marchand A; Butler S; Smets W; Chaltin P; Westby M; Debyser Z; Pickford C
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4365-74. PubMed ID: 22664975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimized binding of substituted quinoline ALLINIs within the HIV-1 integrase oligomer.
    Sun J; Patel K; Hume J; Pigza JA; Donahue MG; Kessl JJ
    J Biol Chem; 2021; 296():100363. PubMed ID: 33539919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus evolution reveals an exclusive role for LEDGF/p75 in chromosomal tethering of HIV.
    Hombrouck A; De Rijck J; Hendrix J; Vandekerckhove L; Voet A; De Maeyer M; Witvrouw M; Engelborghs Y; Christ F; Gijsbers R; Debyser Z
    PLoS Pathog; 2007 Mar; 3(3):e47. PubMed ID: 17397262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,2,3,4-Tetrahydroisoquinolines as inhibitors of HIV-1 integrase and human LEDGF/p75 interaction.
    George A; Gopi Krishna Reddy A; Satyanarayana G; Raghavendra NK
    Chem Biol Drug Des; 2018 Jun; 91(6):1133-1140. PubMed ID: 29405651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LEDGIN-mediated Inhibition of Integrase-LEDGF/p75 Interaction Reduces Reactivation of Residual Latent HIV.
    Vranckx LS; Demeulemeester J; Saleh S; Boll A; Vansant G; Schrijvers R; Weydert C; Battivelli E; Verdin E; Cereseto A; Christ F; Gijsbers R; Debyser Z
    EBioMedicine; 2016 Jun; 8():248-264. PubMed ID: 27428435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of HIV-1 integrase with polypyrimidine tract binding protein and associated splicing factor (PSF) and its impact on HIV-1 replication.
    Yadav P; Sur S; Desai D; Kulkarni S; Sharma V; Tandon V
    Retrovirology; 2019 Apr; 16(1):12. PubMed ID: 31036027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient and stable knockdown of the integrase cofactor LEDGF/p75 reveals its role in the replication cycle of human immunodeficiency virus.
    Vandekerckhove L; Christ F; Van Maele B; De Rijck J; Gijsbers R; Van den Haute C; Witvrouw M; Debyser Z
    J Virol; 2006 Feb; 80(4):1886-96. PubMed ID: 16439544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrase mutants defective for interaction with LEDGF/p75 are impaired in chromosome tethering and HIV-1 replication.
    Emiliani S; Mousnier A; Busschots K; Maroun M; Van Maele B; Tempé D; Vandekerckhove L; Moisant F; Ben-Slama L; Witvrouw M; Christ F; Rain JC; Dargemont C; Debyser Z; Benarous R
    J Biol Chem; 2005 Jul; 280(27):25517-23. PubMed ID: 15855167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.